NIPTE: a multi-university partnership supporting academic drug development

•Academic partnership model for supporting and coordinating academic preclinical development.•Model for providing clinical supplies for academic clinical research.•Providing academic translational centers with access to infrastructure for developing clinical candidates. The strategic goal of academi...

Full description

Saved in:
Bibliographic Details
Published in:Drug discovery today 2013-10, Vol.18 (19-20), p.916-921
Main Authors: Gurvich, Vadim J., Byrn, Stephen R.
Format: Article
Language:English
Subjects:
Academic Medical Centers - economics
Academic Medical Centers - trends
Academies and Institutes - economics
Academies and Institutes - trends
Animals
Drug Discovery - economics
Drug Discovery - trends
Humans
Technology, Pharmaceutical - economics
Technology, Pharmaceutical - trends
Translational Medical Research - economics
Translational Medical Research - trends
Universities - economics
Universities - trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Academic partnership model for supporting and coordinating academic preclinical development.•Model for providing clinical supplies for academic clinical research.•Providing academic translational centers with access to infrastructure for developing clinical candidates. The strategic goal of academic translational research is to accelerate translational science through the improvement and development of resources for moving discoveries across translational barriers through ‘first in humans’ studies. To achieve this goal, access to drug discovery resources and preclinical IND-enabling infrastructure is crucial. One potential approach of research institutions for coordinating preclinical development, based on a model from the National Institute for Pharmaceutical Technology and Education (NIPTE), can provide academic translational and medical centers with access to a wide variety of enabling infrastructure for developing small molecule clinical candidates in an efficient, cost-effective manner.
ISSN:1359-6446
1878-5832
DOI:10.1016/j.drudis.2013.05.014